Covidien plc - COV - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Covidien plc - SIC # 3841

Ticker	Exchange	SIC #	Website	Latest Ticker
COV	New York	3841	http://www.covidien.com	65.25 0.00
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Covidien plc InPlay: Covidien announces clinical trial data showing endoscopic ablation therapy eliminates precancerous esophageal tissue and significantly reduces disease progression - May 22nd, 2013 4:59 am Covidien Announces Clinical Trial Data Showing Endoscopic Ablation Therapy Eliminates Precancerous Esophageal Tissue and Significantly Reduces Disease Progression - May 22nd, 2013 4:59 am FDA Nod for COV's Advanced Nellcor - May 21st, 2013 7:30 am Covidien’s Technology Platform to Diagnose Early Lung Cancer Part of New Guidelines of American College of Chest Physicians - May 21st, 2013 4:59 am Big Companies Borrowing Billions - May 20th, 2013 4:12 pm 4 Healthcare Stock Stories Prescribed For Investors - May 20th, 2013 3:37 pm Covidien Receives FDA 510(k) Clearance for Nellcor™ Pulse Oximetry Motion Claims - May 20th, 2013 6:00 am [video] Companies That Shine After Spinoffs - May 17th, 2013 4:29 pm Cramer: Break-Up Could Boost This Stock 19% - May 17th, 2013 4:02 pm Wall Street Transcript Interview with Mark W. Oelschlager, Portfolio Manager at Oak Associates, Ltd.: A Health Sciences Fund with a Long-Term Focus - May 17th, 2013 8:45 am COVIDIEN PLC Files SEC form 8-K, Results of Operations and Financial Condition - May 17th, 2013 7:10 am Covidien PLC (COV): Today's Featured Health Services Laggard - May 16th, 2013 3:01 pm COVIDIEN PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E - May 16th, 2013 7:54 am Covidien Prices Senior Notes - May 16th, 2013 6:40 am 2 companies to expand operations in Puerto Rico - May 15th, 2013 4:45 pm 2 companies to expand operations in Puerto Rico - May 15th, 2013 4:45 pm Does the Healthcare Industry mean Stability? - May 14th, 2013 4:00 pm COVIDIEN PLC Files SEC form 8-K, Regulation FD Disclosure - May 13th, 2013 11:58 pm Covidien Announces Pricing of $750 Million Senior Notes Offering - May 13th, 2013 2:01 pm Masimo Wins a Major Turkish Client - May 13th, 2013 12:10 pm View All Current Headlines >>